Sectra AB Class B (DE:61L0)
FRANKFURT:61L0
61L0 Stock Chart & Stats
€23.06
€0.30(1.31%)
At close: 4:00 PM EST
€23.06
€0.30(1.31%)
Day’s Range― - ―
52-Week Range€16.01 - €33.52
Previous CloseN/A
Volume0.00
Average Volume (3M)5.00
Market Cap
€5.14B
Enterprise Value€52.36B
Total Cash (Recent Filing)€1.35B
Total Debt (Recent Filing)€109.51M
Price to Earnings (P/E)102.6
Beta0.53
Next Earnings
Jun 05, 2026EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.79
Shares Outstanding182,017,440
10 Day Avg. Volume0
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio3.22
Price to Book (P/B)29.81
Price to Sales (P/S)17.64
P/FCF Ratio70.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€19.38Price Target Upside-15.96% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.34
Revenue Forecast (FY)€377.42M
Bulls Say, Bears Say
Bulls Say
Strong Revenue AccelerationSustained TTM top-line acceleration paired with high operating and net margins indicates robust demand and scalable economics in core businesses. Over 2–6 months this supports durable revenue momentum, margin-driven cash generation, and room to reinvest in product and sales expansion.
Conservative Balance SheetExtremely low financial leverage and expanding equity give the company flexibility to fund growth, absorb shocks, and pursue M&A or R&D without stressing liquidity. High ROE signals efficient capital use, supporting durable shareholder returns and lower refinancing risk.
Recurring, Mission-critical Revenue ModelBusiness mixes of multi-year software contracts, subscriptions and mission-critical deployments create sticky recurring revenue and high customer switching costs. This structural revenue base supports predictable cash flow, renewals-led growth and defensible market position over the medium term.
Bears Say
Margin And Gross-profit VariabilityMaterial year-to-year swings in gross margin and profitability increase execution risk: pricing, mix or cost pressure can quickly erode earnings. For investors this means future margin assumptions are less certain and operational performance must be monitored closely.
Uneven Cash Conversion And FCF DeclineAlthough FCF approximates net income, the recent ~18% YoY decline and historical volatility imply working-capital swings and less predictable cash conversion. That can constrain reinvestment or capital returns and raises the importance of cash management over the next several quarters.
Recent EPS ContractionNegative EPS growth suggests earnings faced near-term pressure despite revenue gains and strong margins. Persistent EPS weakness could signal margin compression, investment dilution, or timing differences in revenue recognition, creating downside risk to expected earnings durability.
Sectra AB Class B News
61L0 FAQ
What was Sectra AB Class B’s price range in the past 12 months?
Sectra AB Class B lowest stock price was €16.01 and its highest was €33.52 in the past 12 months.
What is Sectra AB Class B’s market cap?
Sectra AB Class B’s market cap is €5.14B.
When is Sectra AB Class B’s upcoming earnings report date?
Sectra AB Class B’s upcoming earnings report date is Jun 05, 2026 which is in 2 days.
How were Sectra AB Class B’s earnings last quarter?
Sectra AB Class B released its earnings results on Mar 06, 2026. The company reported €0.075 earnings per share for the quarter, beating the consensus estimate of €0.055 by €0.019.
Is Sectra AB Class B overvalued?
According to Wall Street analysts Sectra AB Class B’s price is currently Overvalued.
Does Sectra AB Class B pay dividends?
Sectra AB Class B does not currently pay dividends.
What is Sectra AB Class B’s EPS estimate?
Sectra AB Class B’s EPS estimate is 0.08.
How many shares outstanding does Sectra AB Class B have?
Sectra AB Class B has 182,017,440 shares outstanding.
What happened to Sectra AB Class B’s price movement after its last earnings report?
Sectra AB Class B reported an EPS of €0.075 in its last earnings report, beating expectations of €0.055. Following the earnings report the stock price went up 12.564%.
Which hedge fund is a major shareholder of Sectra AB Class B?
Currently, no hedge funds are holding shares in DE:61L0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sectra AB Class B
Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. The Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; and project-based development, as well as offers security and threat analyses and system monitoring services for control systems in society's critical operations. The Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies, defense departments, energy companies. Sectra AB (publ) was incorporated in 1957 and is headquartered in Linköping, Sweden.
61L0 Stock 12 Month Forecast
Average Price Target
€19.38
▼(-15.96% Downside)
Technical Analysis
Getinge
―
Vitrolife AB
―
BICO Group AB Class B
―
CellaVision AB
―
Xvivo Perfusion AB
―
Options Prices
Currently, No data available
---